Organizing Committee Members Series of - Stem cells Conferences
International Committee
Dr. Oscar Fornas
Head of CRG and UPF
Flow Cytometry Unit
Pompeu Fabra University | Barcelona
Dr. Oscar Fornas(Biography)
Oscar is the Head of Flow Cytometry Unit at Centre for Genomic Regulation and Pompeu Fabra University in Barcelona, Spain, since 2001, where coordinates the assistance, supervision and training of one of the most advanced flow cytometry platforms in Europe. The Unit assists, supervise and advise more than 300 users from around 120 research groups in Spain and Europe. He supports the use of most flow cytometry applications, develops and implements new ones under scientific community needs. He received his Ph.D in Biochemistry from Autonomous University of Barcelona, Spain and he started to develop advanced Flow Cytometry applications during his first post-doc, at Cancer Research Institute (IRO) in Barcelona, Spain. Oscar has published relevant research papers in leading scientific journals, developing advanced Flow Cytometry methodologies and specific cell sorting. One of those was a relevant new methodological approach for hematopoietic stem cells detection and enumeration by Flow Cytometry with clinical implications. In 2012 he implemented flow karyotyping for chromosomes sorting and, currently is the unique Flow Cytometry Unit in Europe providing this special application as a service. Additionally, he recently combined this application with subsequent chromosome sequencing without amplification by using Oxford Nanopore technologies as a new methodology to assemble structurally very complex chromosomes. Currently, Oscar is focused in develop strategies to detect and isolate nanoparticles by Flow Cytometry. Recently, he has developed an approach for Single-Virus sorting for subsequent single-virus genomics. This methodology allows the possibility to explore the diversity of viruses in different ecosystems and to elucidate the global microbiome, in special, the global virosphere. He has also developed a new approach to identify and isolate Extracellular Vesicles (smaller than 100nm) by Flow Cytometry, to study cell communication and, based on Extracellular Vesicles’ cargo transfer, looking for biomarkers related with diseases. His Unit is becoming a reference site for advanced Flow Cytometry applications and sorting at the single-particle level.
Dr. Oscar Fornas(Research Area)
Three-Dimensional Genomic Structure and Cohesin Occupancy Correlate with Transcriptional Activity during Spermatogenesis. Selective single molecule sequencing and assembly of a human Y chromosome of African origin. Single-virus genomics reveals hidden cosmopolitan and abundant viruses.
Dr. Mohamed Mahmoud El-Shazly
Head of Pharmaceutical Biology Department
German University
egypt
Dr. Mohamed Mahmoud El-Shazly(Biography)
My name is Mohamed Mahmoud El-Shazly. I am the Head of Pharmaceutical Biology Department, Faculty of Pharmacy and Bioethanol, the German University in Cairo, Cairo, Egypt. I was graduated from the Faculty of Pharmacy, Ain-Shams University, Cairo, Egypt, with a general grade excellent with honor in 2000. Following graduation, I pursued my postgraduate studies as a teaching and research assistant at the Department of Pharmacognosy at the same institute. After obtaining my postgraduate diploma, I traveled to Germany (Jacobs University Bremen, Bremen, Germany) to pursue my master and PhD studies. In 2006, I received my master’s degree in nanomolecular science, and I was offered a position at the same institute to complete my PhD focusing on the synthesis of pharmaceutical intermediates and natural products. In 2009, I received my PhD and went back to Egypt to join my home institute as an Assistant Professor at the Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University. In 2011, I received an offer to work at the Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan. I spent there 2.5 years working as a postdoctoral fellow conducting research in different fields including natural products isolation, structural elucidation, and determination of their biological activity. This postdoctoral experience has assisted me to polish my knowledge and experience through guiding master and PhD students in their research. In 2015, I was promoted to associate professor at the Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University. In 2017, I joined the Faculty of Pharmacy and Bioethanol, the German University in Cairo.Additional aspects of my background:Four years of teaching experience as a teaching assistant, Five years of teaching experience as an assistant professor, Four years of teaching experience as an associate professor, Mentor for several undergraduate, master and PhD students Organized scientific and social events on the undergraduate as well as on the faculty members levels.
Dr. Mohamed Mahmoud El-Shazly(Research Area)
Natural products; secondary metabolites with potential biological activities; isolated antioxidant, cytotoxic, hepatoprotective, anti-ulcer and antidiabetic agents from terrestrial plants, microorganisms, and marine organisms.
Michel Bourin
Professor Department of Pharmacology,
University of Nantes
France
Michel Bourin(Biography)
Michel Bourin has held the esteemed position of Professor of Pharmacology at the University of Nantes since 1985. He completed his pharmacist and medical training at Tours University and went on to earn degrees in neuropsychopharmacology, clinical pharmacology, and general pharmacology in Paris. His psychiatric training was accomplished in Nantes. Since 1988, Professor Bourin has served as the Head of Research for Neurobiology of Anxiety and Depression. Additionally, he has been an Adjunct Professor in the Department of Psychiatry at the University of Edmonton (Alberta) since 1995 and a visiting Professor at the University of Craiova (Romania). He has been honored with the title of Doctor Hononoris Causa by the University of Tartu (Estonia) and the University of Craiova (Romania). Currently, he practices as a Psychiatrist in a center for mentally handicapped adults in Montredon, near Narbonne. Over the course of his career, Professor Bourin has made significant contributions to the field of psychopharmacology, having published over 300 original papers and more than 250 educational and review papers in both French and English.
Michel Bourin(Research Area)
Animal models of anxiety and depression, Bipolar disorder and its treatment, Psychotropics development
Jose M. Zuniga
President/CEO
International Association of Providers of AIDS Care
United States
Jose M. Zuniga(Biography)
In 1999, Dr. Jose M. Zuniga assumed the role of President at the International Association of Providers of AIDS Care (IAPAC) after previously serving as the Vice President of the organization. During his tenure as Vice President, he oversaw the organization's efforts related to medical education and technical support. Dr. Zuniga has an extensive background in academia, having delivered lectures at various academic institutions. Furthermore, he has contributed to numerous journals, authored thematic chapters in four books, and edited three books: "The HIV Pandemic" (Oxford University Press, 2006), "Decade of HAART" (Oxford University Press, 2008), and "Advancing the Human Right to Health" (Oxford University Press, 2010). He also serves as the Editor of the Journal of the International Association of AIDS Care Providers (JIAPAC). Dr. Zuniga's contributions extend beyond IAPAC, as he is a member of the Joint United Nations Programme on HIV/AIDS (UNAIDS) Scientific and Technical Advisory Committee and holds a position as an IAPAC Trustee. He is affiliated with the American Public Health Association and the National Hispanic Medical Association.
Jose M. Zuniga(Research Area)
HIV/AIDS Research
Samer Ellahham
Senior Cardiovascular Consultant
The Cleveland Clinic Foundation
United Arab Emirates
Samer Ellahham(Biography)
Dr. Ellahham is a dedicated clinician with board certifications in internal medicine, vascular medicine, cardiology, and quality assurance. He earned his bachelor's and medical degrees from the American University of Beirut. After completing his cardiology residency at the Medical College of Virginia (MCV) in the U.S., he worked in various clinical and managerial roles in Washington DC before relocating to the UAE in 2008. Notably, Dr. Ellahham conducted the first AHA GWTG Heart Failure Initiative outside the U.S. and received the AHA GWTG Award for his contributions. He remains an active clinician and is recertified by the American Board of Cardiology. He's also a fellow of the American College of Cardiology and holds various roles in cardiology-related sections. Additionally, he serves as an editor for several medical journals and has been the Chief Quality Officer at SKMC since 2009, leading successful efforts to improve clinical quality, patient safety, and patient experience.
Samer Ellahham(Research Area)
Dr. Ellahham is a passionate researcher with expertise in various fields, including heart failure, acute coronary syndromes, innovation, digital healthcare, telemedicine, blockchain, patient engagement, safety, risk management, and KPI management. He has received numerous research awards, such as the DuPont Pharmaceuticals Research Award, ACCP Young Investigator Award, Alfred Soffer Research Award, and recognition from the American Heart Association for his contributions to healthcare research.
Samer Ellahham
Senior Cardiovascular Consultant
The Cleveland Clinic Foundation
United Arab Emirates
Samer Ellahham(Biography)
Dr. Ellahham is a dedicated clinician with board certifications in internal medicine, vascular medicine, cardiology, and quality assurance. He earned his bachelor's and medical degrees from the American University of Beirut. After completing his cardiology residency at the Medical College of Virginia (MCV) in the U.S., he worked in various clinical and managerial roles in Washington DC before relocating to the UAE in 2008. Notably, Dr. Ellahham conducted the first AHA GWTG Heart Failure Initiative outside the U.S. and received the AHA GWTG Award for his contributions. He remains an active clinician and is recertified by the American Board of Cardiology. He's also a fellow of the American College of Cardiology and holds various roles in cardiology-related sections. Additionally, he serves as an editor for several medical journals and has been the Chief Quality Officer at SKMC since 2009, leading successful efforts to improve clinical quality, patient safety, and patient experience.
Samer Ellahham(Research Area)
Dr. Ellahham is a passionate researcher with expertise in various fields, including heart failure, acute coronary syndromes, innovation, digital healthcare, telemedicine, blockchain, patient engagement, safety, risk management, and KPI management. He has received numerous research awards, such as the DuPont Pharmaceuticals Research Award, ACCP Young Investigator Award, Alfred Soffer Research Award, and recognition from the American Heart Association for his contributions to healthcare research.